Varian Medical says launches 'game-changing' cancer treatment product
Varian announced Saturday it is introducing the Halcyon system, "an entirely new device for cancer treatment. Engineered to revolutionize clinical workflow, Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy." The company continued, "With its streamlined workflow, Halcyon only requires nine steps from the start to the end of treatment compared to up to more than 30 steps with older technologies nearing end of life. Halcyon is well suited to handle the majority of cancer patients, offering advanced treatments for prostate, breast, head & neck, and many other forms of cancer." The treatment planning for Halcyon is supported by Varian's Eclipse treatment planning software and is 510k pending. Halcyon has received CE mark and is currently 510k pending and not for sale in all markets.